tenofovir – SASHA: South Australian Sexual Health Awareness

Updated guidelines for PEP (Post-Exposure Prophylaxis) after non-occupational and occupational exposure to HIV 

2 Min Read

U

Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM), June 2023 ASHM has updated the National Guidelines for Post-Exposure Prophylaxis (PEP) after non-occupational and occupational exposure to HIV . These guidelines outline the updated Australian recommendations for human immunodeficiency virus (HIV) post-exposure prophylaxis (PEP) following potential or known exposure...

Read on Read later

Utilisation of pre-exposure prophylaxis (PrEP) for HIV prevention in the Australian general practice setting

By J Pope

In HIV

2 Min Read

U

Chidwick Kendal, Pollack Allan, Busingye Doreen, Norman Sarah, Grulich Andrew, Bavinton Benjamin, Guy Rebecca, Medland Nick (2022) Utilisation of pre-exposure prophylaxis (PrEP) for HIV prevention in the Australian general practice setting: a longitudinal observational study. Sexual Health 19, 101-111. Abstract: Background: Pre-exposure prophylaxis (PrEP) became available through the Australian...

Read on Read later

Trans and cis women and men all have similar levels of PrEP drugs in blood

By J Pope

In Gender & Sex, HIV

1 Min Read

T

nam/aidsmap, 7 September 2020 A study in which 24 trans women and 24 trans men who were taking gender-affirming hormone therapy were directly observed to take a daily dose of the standard formulation of the HIV prevention medication PrEP found that the levels of the two PrEP drugs tenofovir and emtricitabine were similar to the levels seen in similar cis men and women, and were all above levels...

Read on Read later

Information about TRUVADA and ATRIPLA delisting

By J Pope

In Gay Lesbian & Bisexual Health, HIV, LGBTIQ+ issues

1 Min Read

I

Australian Federation of AIDS Organisations (AFAO), March 30th 2020 From 1 April 2020 Truvada for HIV treatment and for pre-exposure prophylaxis (PrEP) will no longer be available through the Pharmaceutical Benefits Scheme (PBS). There are alternatives to Truvada for PrEP in Australia. Community members eligible for PrEP can access generic versions of Truvada supplied by Apotex, Mylan and Lupin...

Read on Read later

Transgender women taking PrEP have lower levels of PrEP drugs than cisgender men

By J Pope

In Gender & Sex, HIV

1 Min Read

T

aidsmap/nam, November 9th 2018 A study presented at October’s HIV Research for Prevention conference (HIVR4P) in Madrid shows that transgender women who are taking feminising hormones and also taking pre-exposure prophylaxis (PrEP) have levels of the PrEP drugs tenofovir and emtricitabine in their blood that are about 25% lower than those in cisgender men, and levels in rectal tissue cells...

Read on Read later

HIV PrEP available on PBS in Australia from 1 April / Links to Clinical Resources

By J Pope

In Aboriginal Health, Gay Lesbian & Bisexual Health, HIV, Mental health & sexual health, Multicultural communities, People Who Inject Drugs / AOD, Safer sex, Sexual Activity

2 Min Read

H

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 21 March 2018 ASHM congratulates the Federal Health Minister, the Hon. Greg Hunt’s announcement of a landmark in HIV prevention to approve HIV-prevention drugs – tenofovir with emtricitabine, known as PrEP – on the Pharmaceutical Benefits Scheme from 1 April, thereby providing broader access for any doctor or general...

Read on Read later

Tagtenofovir